Can common diabetes drug help thalassemia patients need fewer transfusions?
NCT ID NCT06606886
First seen Apr 26, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study tested two drugs, hydroxyurea and metformin, in 96 people with transfusion-dependent beta-thalassemia to see if they could reduce the need for blood transfusions. Participants took one of the drugs daily for a year. The goal was to measure changes in fetal hemoglobin, transfusion frequency, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION DEPENDENT BETA THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bahria University Health Sciences Campus
Karachi, Sindh, Pakistan
Conditions
Explore the condition pages connected to this study.